Glimepiride; Pioglitazone Hydrochloride Patent Expiration

Glimepiride; Pioglitazone Hydrochloride is Used for improving glycemic control in patients with type 2 diabetes. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Duetact on Jul 28, 2006. 2 different companies have introduced drugs containing Glimepiride; Pioglitazone Hydrochloride.


Glimepiride; Pioglitazone Hydrochloride Patents

Given below is the list of patents protecting Glimepiride; Pioglitazone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Duetact US8071130 Solid preparation Jun 08, 2028 Takeda Pharms Usa
Duetact US7700128 Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester Jan 30, 2027 Takeda Pharms Usa
Duetact US6303640 Pharmaceutical composition Aug 09, 2016

(Expired)

Takeda Pharms Usa
Duetact US6150383 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Duetact US6211205 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Duetact US6329404 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Duetact US7538125 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa



Glimepiride; Pioglitazone Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Glimepiride; Pioglitazone Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Glimepiride; Pioglitazone Hydrochloride.

Given below is the list of companies who have filed for Glimepiride; Pioglitazone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Glimepiride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG; 30MG

tablet Prescription ORAL AB Jan 4, 2013
4MG; 30MG

tablet Prescription ORAL AB Jan 4, 2013


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited